Author:
Simpson G R,Horvath A,Annels N E,Pencavel T,Metcalf S,Seth R,Peschard P,Price T,Coffin R S,Mostafid H,Melcher A A,Harrington K J,Pandha H S
Publisher
Springer Science and Business Media LLC
Reference63 articles.
1. Adam L, Black PC, Kassouf W, Eve B, McConkey D, Munsell MF, Benedict WF, Dinney CP (2007) Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer. J Urol 177: 1900–1906
2. Adusumilli PS, Chan MK, Chun YS, Hezel M, Chou TC, Rusch VW, Fong Y (2006) Cisplatin-induced GADD34 upregulation potentiates oncolytic viral therapy in the treatment of malignant pleural mesothelioma. Cancer Biol Ther 5: 48–53
3. Andreansky SS, He B, Gillespie GY, Soroceanu L, Markert J, Chou J, Roizman B, Whitley RJ (1996) The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors. Proc Natl Acad Sci USA 93: 11313–11318
4. Anundi I, de GH (1989) Hypoxic liver cell death: critical Po2 and dependence of viability on glycolysis. Am J Physiol 257: G58–G64
5. Bateman A, Bullough F, Murphy S, Emiliusen L, Lavillette D, Cosset FL, Cattaneo R, Russell SJ, Vile RG (2000) Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth. Cancer Res 60: 1492–1497
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献